Global University Venturing

Touchstone Innovations has co-led a $6.75m series A round for edtech developer Sam Labs after it pumped $2.9m into the business in May 2016.

A new spinout from Deakin University will market a personal assistant and marketing platform already used on campus.

The National University of Singapore spinout has secured an undisclosed amount to bring its blockchain platform through public testing scheduled for December 2017.

Unternehmertum Venture Capital Partners has returned to back a series B round for Dynamic Biosensors, a spinout from Technical University of Munich.

The Pittsburgh spinout is building a precision diagnostic platform that uses genomics to underpin research into conditions such as chronic pancreatic disease.

Neophore was launched by University of Cambridge biopharmaceutical developer PhoreMost in May 2017 to home in on potential immunotherapies for cancer.

Pennsylvania spinout Apellis Pharmaceuticals has floated on the Nasdaq Global Select Market after raising $150m in its initial public offering.

Graphcore, whose roots can be traced back to University of Bristol, has added $50m to its coffers thanks to a series C round backed by Bosch, Dell and Samsung.

Immunotherapy developer Arcus Biosciences, backed by Stanford University, has raised series C funding from a GV-led consortium that included Celgene and Taiho.

The cash will be used for a recruitment drive as QCI begins to ramp up the development of modules that could eventually be used for general purpose quantum computing.

EMBL-backed Arsanis hopes to sell 3,125,000 shares priced at $15 to $17 and raise a total of up to $61m in its initial public offering.